Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).
Clinical trial NCT00792623 · COMPLETED
Trial details
- NCT number
- NCT00792623
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-08
- Primary completion
- 2007-09-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.